Three prenylated indole alkaloids (1-3), including two new penicimutamides D-E (1-2), were isolated from a diethyl sulfate mutant of the marine-derived fungus Penicillium purpurogenum G59. The structures of 1-3, and their absolute configurations, were determined by spectroscopic methods, including X-ray crystallography and CD analyses. HPLC-UV and HPLC-MS analyses showing that 1-3 were only produced in the mutant evidenced that the silent biosynthetic pathways that produce 1-3 in the parental strain are activated by DES mutagenesis.
Prenylated indole alkaloids (PIAs) are a broad class of secondary fungal metabolites with a bicyclo[2.2.2]diazaoctane core ring system. 1 Included in this group are brevianamides, 2 notoamides, 3 stephacidins, 4 versicolamides, 5 paraherquamides, 6 malbrancheamides 7 and marcfortines. 8 Total syntheses, 9 biomimetic syntheses 10 and biosyntheses 11 of PIAs, focusing on formation of the core ring system, have been extensively investigated because of the interesting structures of the PIAs.
In our previous work, 12 three rare carbamate-containing PIAs, penicimutamides A-C, were isolated from a fungal mutant AD-2-1 of a marine-derived Penicillium purpurogenum G59 via diethyl sulfate (DES) mutagenesis. As a continuation of this, we herein report on three other PIAs, including two new penicimutamides D-E (1-2 in Fig. 1 ) and a known one (3). These compounds were produced in the same solid culture by the mutant AD-2-1 by activating silent pathways in parent G59 strain. The mutant AD-2-1 was selected by treating Penicillium purpurogenum G59 spores with 1% (v/v) DES in 50% (v/v) DMSO at 4 C for 1 d. This produced a series of novel lipopeptides in liquid culture via the activation of pathways that were silent in the G59 strain. 13 To obtain new fungal secondary metabolites, the one-strainmany-compounds approach, 14 chemical epigenetics 15 and co-cultivation 16 have been used to activate silent pathways by varying environmental factors for growth of the producing strains. In our previous work, 17 a series of new methods 17a-c based on ribosome engineering 18 were developed for fungi, and several new secondary metabolites were isolated from the mutants. 17c-e During this study, a practical mutagenesis strategy using DES was developed to activate silent fungal pathways. 13, 19 A diverse range of secondary metabolites were isolated from the DES mutant of Penicillium purpurogenum G59 by activating pathways that were silent in the parent strain via DES mutagenisis. 19a As reported in our previous work, the mutant AD-2-1 and parental G59 strains were fermented concurrently under the same conditions at 28 C for 50 d using rice as a solid substrate fermentation medium to obtain methanol (MeOH) extracts of their cultures. These cultures inhibited K562 cells with inhibition rates of 62.5% and 6.1% at 100 mg mL À1 , respectively. Production of new metabolites was tracked to guide separation of the mutant extract, and resulted in the isolation of 1-3 (Table 1) .
Aer analysis by HR-ESI-MS, penicimutamide D (1) was assigned the molecular formula C 21 2) . All of the above spin systems were the same as those for the known compound 3, which suggested 1 had the same skeleton as 3. When the 13 C NMR spectrum of 1 was compared with that of 3, the biggest differences were the absence of a sp 2 carbon signal (C-14 of 3) and appearance of an oxygenated sp 3 carbon signal (C-14 of 1). So, it could be deduced that 1 is an oxidative product of 3 with a hydroxyl group at C-14. In addition the double bond was transferred from C 2 ]C 14 to C 1 ]C 2 , which resulted in a high-eld shi of C-2 from d C 142.2 (in 3) to 192.6 (in 1). This gave a planar structure ( Fig. 1) , which was also supported by further NMR data (Fig. 2) .
The NOEs observed in the NOESY of 1 between H-4/Hb-11, H-4/Hb-13, H-4/Hb-5, H-4/H 3 -21 and H 3 -21/Ha,b-5 indicated that ring C had a chair conformation and ring D had a boat conformation with CH 3 -22, HO-C 14 groups and the lactam group located on the same face. The NOEs between Hb-5/Hb-7 and Ha-9/Ha-11 showed that the E ring had an envelope conformation with N-10 upwarped as shown in Fig. 2 . Thus, the relative conguration was established.
To determine the absolute conguration of 1, single-crystal X-ray diffraction using Cu Ka radiation for 1 was performed. An ORTEP drawing of the crystallographically determined structure of 1 is depicted in Fig. 3 . The relative conguration of 1 determined was in accordance with the result based on NOEs. But the Flack parameter was À0.2 (2), which was not perfect enough to determine the absolute conguration.
To conrm the absolute conguration of 1, TDDFT electronic CD (ECD) calculations 20,21 for 1 and its enantiomer were performed. The calculated ECD of 1 agreed with the measured CD data (Fig. 4) , and showed that the absolute conguration was 4R, 6S, 12S, 14S. Penicimutamide E (2) was assigned the molecular formula C 21 H 25 N 3 O 1 by HR-ESI-MS (m/z 336.2070 [M + H] + , calcd for C 21 H 26 N 3 O 2 336.2072), which was the same as that of the known compound 3. The UV and IR spectra were also identical to those of 3. The similar 1 H and almost identical 13 C NMR data indicated that 2 had the same planar structure as 3, which was also supported by other NMR data.
The NOEs observed in the NOESY of 2 between H-4/Hb-11, H-4/Hb-13, H-4/Hb-5, H-4/H 3 -21, H 3 -21/Ha,b-5, Hb-5/Hb-7 and Ha-9/Ha-11 established the relative conguration of 2 as shown in Fig. 5 . To determine the absolute conguration of 2, TDDFT ECD calculations 20,21 for 2 and its enantiomer were performed. The calculated ECD of 2 agreed with the measured CD data (Fig. 6) , and the absolute conguration of 2 was determined as 4R, 6S, 12S.
Compound 3 was obtained as a crystalline powder. The 1 H and 13 C NMR data were almost identical to the published data of (+)-premalbrancheamide, 22 which indicated that 3 had the same planar structure as (+)-premalbrancheamide. The NOEs observed in the NOESY spectrum (Fig. 7) also indicated that 3 had the same relative stereochemistry as (+)-premalbrancheamide (Fig. 6) . The [a] D of 3 (+3.2 ) was smaller than that of (+)-premalbrancheamide (+15 ), 23 and there was no Cotton effect evident in the CD spectrum of 3. This indicates that 3 is a racemic mixture of (AE)-premalbrancheamide. According to the HPLC analysis of compound 3 on a CHIRALPAK IE column with 65% MeOH, the (+)-premalbrancheamide content was about 56%, and the (À)-premalbrancheamide content was about 44% (Fig. 8) . The racemic mixture was not separated because we only had a small quantity of 3.
The MeOH extracts from the mutant AD-2-1 and parent G59 strains were analyzed by HPLC with a photodiode array detector and HPLC-ESI-MS using 1-3 as reference standards. The retention times and the UV and MS spectra ( Fig. S2 and S3 in the ESI †) showed that 1-3 were only present in the mutant extract and not in the parent extract. This is evidence that 1-3 are produced in mutant AD-2-1 following activation of biosynthetic pathways that are silent in the parent G59 strain and subsequently activated by the DES mutagenesis process in the mutant. Fig. 3 The crystal structure of 1. Fig. 4 Measured and calculated ECD spectra of 1 and its enantiomer in MeOH. As reported in our previous work, 12 1 and 2 were both intermediates in plausible biosynthetic pathways for penicimutamides A-C. Plausible biosynthetic pathways for 3 have been reported in earlier studies. 22, 23 (+)-Premalbrancheamide was detected in one study, 22 and was subsequently isolated from the fermentation product of Malbranchea aurantiaca. 24 (À)-Premalbrancheamide was isolated for the rst time in the present study.
To evaluate the inhibitory effect on human cancer cell lines, 1-3 and 5-uorouracil were tested against human K562, HL-60, HeLa and BGC-823 cell lines at 100 mg mL À1 by the MTT assay. Compounds 1-3 only showed weak inhibition of the above four cell lines with inhibition rates ranging from 2% to 27%.
Conclusions
In our previous work, three rare carbamate-containing alkaloids, penicimutamides A-C, were isolated from the DES mutant AD-2-1 obtained from the marine-derived fungus Penicillium purpurogenum G59, and plausible biosynthetic pathways from the precursor deoxybrevianamide E were reported. 12 In the present work, two new prenylated indole alkaloids, penicimutamides D-E, which might be intermediates in the biosynthesis of penicimutamides A-C, were isolated from the mutant AD-2-1. The discovery of penicimutamides A-E from the mutant AD-2-1 strain demonstrates the effectiveness of our previously reported DES mutagenesis strategy 19 for obtaining new bioactive compounds from silenced fungal pathways. The present work conrms the proposed biosynthetic pathway of penicimutamides A-C.
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